| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 671139 | Null | 0.0065871594677386 | 0.11495433 |
| NSC 683664 | 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[3-(dimethylamino)- 1-oxopropoxy)-19-[(2-propenyl)amino]-,stere | 0.0065871594677386 | 0.18415459 |
| NSC 689227 | 3-Hydroxy-4-[4-[3-(4-isopropylcyclohexanony)butyl]]cyclo pentanone tert-butyldimethylsilyl ether | 0.0065871594677386 | 0.2299748 |
| NSC 698395 | Morpholine, 4,4'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1E,3E)- | 0.0065871594677386 | 0.21298783 |
| NSC 702415 | Null | 0.0065871594677386 | 0.15111038 |
| NSC 742295 | (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.0065871594677386 | 0.086547038 |
| NSC 665534 | 5-Quinolinesulfonic acid, 7,7'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)iminocarbonyl]]bis[8-hydroxy-, tetrasodium salt | 0.0070787592519192 | 0.25018757 |
| NSC 671135 | Null | 0.0070787592519192 | 0.0019360449 |
| NSC 679095 | Null | 0.0070787592519192 | -0.17724081 |
| NSC 691895 | Null | 0.0070787592519192 | 0.42142069 |